Evidence map›Paper›PMID 41280092›Full record

ArticlebioRxiv : the preprint server for biology2025

Pseudouridine selects RNAs for extracellular transport.

Alessandro Scacchetti, Emily J Shields, Lauren N Reich, John F Doherty, Julia A Tasca, Grace E Lee, Richard Lauman, Natali L Chanaday, Benjamin A Garcia, Colin C Conine and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Alessandro ScacchettiEpigenetics Institute and Department of Cell and Developmental Biology; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-0254-3717
Emily J ShieldsEpigenetics Institute and Department of Cell and Developmental Biology; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Lauren N ReichEpigenetics Institute and Department of Cell and Developmental Biology; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
John F DohertyEpigenetics Institute and Department of Cell and Developmental Biology; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Julia A TascaEpigenetics Institute and Department of Cell and Developmental Biology; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Grace E LeeDepartments of Genetics and Pediatrics; Epigenetics Institute; Institute of Regenerative Medicine; Center for Research on Reproduction and Women's Health; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Richard LaumanEpigenetics Institute and Department of Cell and Developmental Biology; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Natali L ChanadayDepartments of Physiology and Neuroscience; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Benjamin A GarciaDepartment of Biochemistry and Molecular Biophysics; Washington University School of Medicine, St. Louis, Missouri, United States.
Colin C ConineDepartments of Genetics and Pediatrics; Epigenetics Institute; Institute of Regenerative Medicine; Center for Research on Reproduction and Women's Health; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Roberto BonasioEpigenetics Institute and Department of Cell and Developmental Biology; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-0767-0889

Funding

Translational Research Support CoreP30ES013508 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI A. Clementina Mesaros · 2006 to 2026
$35.3M
Epigenetic engrams in planariansDP1NS148061 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI Roberto Bonasio · 2025 to 2026
$2.3M
Developing C. elegans as a model to understand tRNA-fragment biogenesis and functionR35GM151087 · NIGMS · CHILDREN'S HOSP OF PHILADELPHIA · PI Colin Conine · 2023 to 2026
$1.8M
Revealing the RNA foundations of chromatin-based epigeneticsR35GM153281 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI Roberto Bonasio · 2024 to 2026
$1.1M
NIEHS NIH HHS P30 ES013508NIGMS NIH HHS R35 GM151087NIGMS NIH HHS R35 GM153281NINDS NIH HHS DP1 NS148061
6 · The paper itself

Abstract

RNAs move through the extracellular space to transmit information between cells, including mammalian neurons, yet how specific RNAs are channeled into these extracellular routes is unknown. Using genome-wide CRISPR screening, proteomics, and high-sensitivity transcriptomics in a neuronal cell line, we identify domesticated retroviral proteins and RNA-modifying enzymes that regulate RNA loading into and transportation via extracellular vesicles. We show that the pseudouridine synthase PUS1 is a key determinant of RNA trafficking, and that its catalytic product in RNA, pseudouridine, is both necessary and sufficient for extracellular RNA export. We further show that myosin light chain 6 (MYL6) is a pseudouridine-binding protein required for secretion of synthetic and endogenous RNAs. These findings reveal a biochemical code linking chemical RNA modification to extracellular transport, and establish a framework to study the function of extracellular RNAs in the nervous system and beyond.

Identifiers

PMID41280092
PMCPMC12636487

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.